Melanoma patient imaging in the era of effective systemic therapies
| Autor: | Robyn P. M. Saw, M.D. Stodell, Roger F. Uren, John F. Thompson, Louise Emmett, Rony Kapoor |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Diagnostic Imaging
medicine.medical_specialty Skin Neoplasms Metastatic melanoma Disease Primary disease 030218 nuclear medicine & medical imaging Imaging modalities 03 medical and health sciences 0302 clinical medicine medicine Humans Medical physics Intensive care medicine Melanoma Neoplasm Staging Melanoma patient Sentinel Lymph Node Biopsy business.industry General Medicine medicine.disease Oncology Lymphatic Metastasis 030220 oncology & carcinogenesis Surgery business |
| Zdroj: | European Journal of Surgical Oncology (EJSO). 43:1517-1527 |
| ISSN: | 0748-7983 |
| Popis: | Imaging plays a critical role in the current multi-disciplinary management of patients with melanoma. It is used for primary disease staging, surgical planning, and surveillance in high-risk patients, and for monitoring the effects of systemic or loco-regional therapies. Several different imaging modalities have been utilised in the past. Contemporary imaging practises vary geographically depending on clinical guidelines, physician preferences, availability and cost. Targeted therapies and immunotherapies have revolutionised the treatment of patients with metastatic melanoma over the last few years. With this have come new patterns of disease that were not observed after conventional therapies, and new criteria to assess therapeutic responses. In this article we review the role of imaging for patients with melanoma in the era of effective systemic therapies and discuss likely future developments. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect